Literature DB >> 96404

Hurler/Scheie phenotype. Report of an inbred sibship with tapeto-retinal degeneration and electron-microscopie examination of the conjuctiva.

O A Jensen, C Pedersen, M Schwartz, S Vestermark, M Warburg.   

Abstract

An inbred sibship with corneal opacities and deficient alpha-L-iduronidase activity showed signs of a Hurler/Scheie phenotype. The children were of normal intelligence. In one of the children, electron microscopy of the conjunctiva showed membrane-bound intracellular vacuoles and the electroretinogram was extinguished. The consanguinity of the parents is taken to indicate the presence of homozygosity of a mutant gene different from both the Hurler and Scheie mutants, thus rejecting the concept of a genetic compound in our patients.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 96404     DOI: 10.1159/000308739

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  4 in total

1.  Arylsulphatase B studies in skin fibroblasts from patients with Maroteaux--Lamy syndrome with special reference to electrophoretic mobility and prenatal diagnosis.

Authors:  M Schwartz; N J Brandt; E Christensen; C Pedersen
Journal:  J Inherit Metab Dis       Date:  1980       Impact factor: 4.982

2.  Hurler-Scheie phenotype: a report of two pairs of inbred sibs.

Authors:  N Kaibara; M Eguchi; K Shibata; K Takagishi
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

3.  Hybridization studies of fibroblasts from Hurler, Scheie, and Hurler/Scheie compound patients: support for the hypothesis of allelic mutants.

Authors:  J J Fortuin; W J Kleijer
Journal:  Hum Genet       Date:  1980-02       Impact factor: 4.132

Review 4.  Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology.

Authors:  Christiane S Hampe; Julie B Eisengart; Troy C Lund; Paul J Orchard; Monika Swietlicka; Jacob Wesley; R Scott McIvor
Journal:  Cells       Date:  2020-08-05       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.